Search Results - "University of Texas MD Anderson Cancer Center"

CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery by Wang Fang, Ye Yanfen, Xu Xia, Zhou Xuehui, Wang Jinhua, Chen Xiaoxiang

Connect to this object online.

Costs of Biopsy and Complications in Patients with Lung Cancer by Chiu YW, Kao YH, Simoff MJ, Ost DE, Wagner O, Lavin J, Culbertson RA, Smith DG

Connect to this object online.

Length of stay, mortality, and readmissions among Medicare cancer patients treated with glucarpidase and conventional care: a retrospective study by Demiralp B, Koenig L, Kala J, Feng C, Hamlett EG, Steele-Adjognon M, Ward S

Connect to this object online.

Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure–response analysis of a Phase III study by Wang X, Roy A, Hochhaus A, Kantarjian HM, Chen TT, Shah NP

Connect to this object online.

Novel Clinically Weight-Optimized Dynamic Conformal Arcs (WO-DCA) for Liver SBRT: A Comparison with Volumetric Modulated Arc Therapy (VMAT) by Saglam Y, Bolukbasi Y, Atasoy AI, Karakose F, Budak M, Alpan V, Topkan E, Selek U

Connect to this object online.

Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells by Kim YW, Kim EY, Jeon D, Liu JL, Kim H, Choi JW, Ahn WS

Connect to this object online.

GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer by Zhang X, Huang M, Wu X, Kadlubar S, Lin J, Yu X, Fan C, Ning B, Kadlubar FF

Connect to this object online.

Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas by Topkan E, Selek U, Kucuk A, Pehlivan B

Connect to this object online.

Reverse transcription loop-mediated isothermal amplification (RT-LAMP) for point-of-care detection of SARS-CoV-2: a clinical study to evaluate agreement with RT-qPCR by Mary Natoli, PhD, Kathryn Kundrod, PhD, Megan Chang, BA, Chelsey Smith, BE, Sai Paul, BS, Karen Eldin, MD, Keyur Patel, MD, Ellen Baker, MD, Kathleen Schmeler, MD, Rebecca Richards-Kortum, PhD

Connect to this object online.

Construction of the Interaction Network of Hub Genes in the Progression of Barrett’s Esophagus to Esophageal Adenocarcinoma by Li K, Duan P, He H, Du R, Wang Q, Gong P, Bian H

Connect to this object online.

High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients by Kucuk A, Topkan E, Selek U, Haksoyler V, Mertsoylu H, Besen AA, Pehlivan B

Connect to this object online.

The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy by Topkan E, Selek U, Pehlivan B, Kucuk A, Haksoyler V, Kilic Durankus N, Sezen D, Bolukbasi Y

Connect to this object online.

Relevance of PD-L1 Non-Coding Polymorphisms on the Prognosis of a Genetically Admixed NSCLC Cohort by Machado-Rugolo J, Gutierrez Prieto T, Fabro AT, Parra Cuentas ER, Sá VK, Baldavira CM, Rainho CA, Castelli EC, Farhat C, Takagaki TY, Nagai MA, Capelozzi VL

Connect to this object online.